Journal of Gastrointestinal Infections

Register      Login

VOLUME 4 , ISSUE 1 ( 2014 ) > List of Articles

ORIGINAL ARTICLE

Evaluation of Antibacterial and Anti-inflammatory Potential of Withania Somnifera (Ashwagandha) against Salmonella Enterica Serovar Typhimurium

Praveen Rishi, Tanya Sathu, Aman Preet Singh, Simran Preet

Keywords : Ashwagandha, antibacterial activity, ex-vivo, immuno-modulatory, in-vitro, in-vivo, minimum inhibitory concentration.

Citation Information : Rishi P, Sathu T, Singh AP, Preet S. Evaluation of Antibacterial and Anti-inflammatory Potential of Withania Somnifera (Ashwagandha) against Salmonella Enterica Serovar Typhimurium. J Gastrointest Infect 2014; 4 (1):23-32.

DOI: 10.5005/jp-jogi-4-1-23

License: CC BY-SA 4.0

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background & Objectives: The usual approach to treat Salmonella infections has been the use of conventional antibiotics, but the emergence of MDR (multidrug-resistant) strains and their undesirable effects has diverted the scientific interest towards the use of natural antibacterial and anti-inflammatory compounds. In this context, Withania somnifera (ashwagandha) is one such alternative, which has been safely used for centuries in Indian Ayurvedic medicine for the treatment of various ailments. The present study was therefore, planned to evaluate the antibacterial, anti-inflammatory (edema) and immuno-modulatory potential of the purified whole root extract of Withania somnifera against Salmonella enterica serovar Typhimurium. Material and Methods: Female inbred BALB/c mice, 4-6 weeks old (16-22 gm in weight), were procured from the Central Animal House, Panjab University, Chandigarh (India). Results: Well-diffusion assay and CFU (colony forming units) enumeration confirmed the in-vitro inhibitory potential of Withania somnifera. The anti-inflammatory potential of ashwagandha was confirmed by mouse paw oedema test and flicking response. Further, a significant decrease in MDA (malondialdehyde) and increase in SOD (superoxide dismutase) levels revealed the modulatory effects of ashwagandha in terms of macrophage functions. Withania somnifera also demonstrated excellent in-vivo potency against serovar Typhimurium as evident by reduction in the number of Salmonellae in the liver, spleen and intestine along with histological studies. Interpretations & Conclusion : From the present study, it may be concluded that Withania somnifera possesses strong antibacterial as well as anti-inflammatory potential against Salmonella enterica serovar Typhimurium as evidenced by in-vitro, ex-vivo and in-vivo tests.


PDF Share
  1. Giannella RA, Gots RE, Charney AN, Greenough WB, Formal SB. Pathogenesis of Salmonella-mediated intestinal fluid secretion. Gastroenterol 1975;69:1238-45.
  2. Giannella RA. Importance of the intestinal inflammatory reaction in Salmonella-mediated intestinal secretion. Infect Immun 1979;23:140-5.
  3. Henson R, Johnston T. Virulence associated with inflammatory response in case of Salmonella infection. J Microbiol 1987;24:23-32.
  4. Ballmer G, Marshall PA, Olsen SJ, Villar RG. Effect of Reactive oxygen species or radicals on the generation of PUFA's in the damage and introduction about the DNAdamage. Ind J Exp Biol 1994;35:345-56.
  5. Threlfall EJ, Frost JA, Ward LR, Rowe B. Increasing spectrum of resistance in multi-resistant Salmonella enterica serovar Typhimurium. Lancet 1996;347: 1053-4.
  6. Rishi P, Preet S, Kaur P. Effect of L. plantarum cell free extract and cotrimoxazole against Salmonella enterica serovar Typhimurium: a possible adjunct therapy. Ann Clin Microbial Antimicrob 201;10:9-17.
  7. Angulo FJ, Johnson KR, Tauxe RV, Cohen ML. Origins and consequences of antimicrobial resistant non typhoidal Salmonella, implications for the use of flouroquinolones in food animals. Microb Drug Resist 2000;6:77-83.
  8. Gross U, Tschape H, Bednarek I, Frosch M. Antibiotic resistance in Salmonella enterica serotype Typhimurium. Eur J Clin Microbiol Infect Dis 1998;17:385-7.
  9. O'Brien TF. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 2002;34:S78-S84.
  10. Dundas Y, Heffron G, Kyumer U, Serent R. Studies on the toxicity effects due to the use of antibiotics and disruption of the normal flora of the host. Eur J Med Microbiol 1999; 23:345-56.
  11. Chopra RN, Chopra IC, Handa KL, Kapur LD. Indigenous drugs of India. UN Dhar and Sons, Calcutta, India, 1958.
  12. Mirjalili MH, Moyano E, Bonfill MR, Cusido M, Palazon J. Steroidal Lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 2009;14: 2373-93.
  13. Mabberley DJ. The Plant Book, 2nd edn. Cambridge University Press, Cambridge, 1997.
  14. Doaigey AR. Occurrence, type and location of calcium oxalate crystals in leaves and stem of 16 species of poisonous plants. Am J Bot 1991;78:1608-16.
  15. Khanna PK, Kumar A, Ahuja A, Kaul MK. Biochemical composition of roots of Withania somnifera (L.) dunal. Asian J Plant Sci 2006;5:1061-3.
  16. Takeuchi K, Tomita H, Fujimoto S, Kudo M, Kuwano H, Ike Y. Antibacterial activity of plant extracts and phytochemicals. FEMS Microbiol Lett 2005;243:347-54.
  17. Dhuley JN. Therapeutic efficacy of ashwagandha against experimental aspergillosis in mice. Immunopharmacol Immunotoxicol 1998;20:191-8.
  18. Ziauddin P, Phansalkar N, Pataki M, Diwanay PS, Patwardhan B. Studies on the immuno-modulatory effects of ashwagandha. J Ethnopharmacol 1996;50:69-76.
  19. Elsakka M, Grigorescu EU, Stanescu U, Dorneanu V. New data referring to chemistry of Withania somnifera species. Rev Med Chir Soc Med Nat Iasi 1990; 94:385-7.
  20. Arora S, Dhillon S, Rani G, Nagpal A. The in vitro antibacterial synergistic activities of Withania somnifera extracts. Fitoterapia 2004;75:385-8.
  21. Sundaram S, Dwivedi P, Purwar S. In vitro evaluation of antibacterial activities of crude extracts of Withania somnifera (Ashwagandha) to bacterial pathogens. Asian J Biotechnol 2011;3(2):194-9.
  22. Owais M, Sharad KS, Shehbaz A, Saleemuddin M. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 2005; 12:229-35.
  23. Sarkar PK, Banerjee S. Antibacterial activity of the bacterial isolates obtained from natural habitats. J Food Sci Technol 1996;33:231-3.
  24. Chander H, Majumdar S, Sapru S, Rishi P. Macrophage cell death due to Salmonella enterica serovar Typhi and its role in apoptosis. Microbiol Immunol 2005;49:323-30.
  25. Wills ED. Mechanism of lipid peroxidation formation in animal tissues. J Biochem 1966;99:667-76.
  26. Lowry OH, Rosbrough NJ, Randal RJ. Protein estimation with Follin's reagent. J Biol Chem 1951;193:265-75.
  27. Kono Y. Generation of superoxide radical during autooxidation of hydroxylamine and an assay of superoxide diamutase. Arch Biochem Biophy 1978;186:189-95.
  28. Palazon R. In vivo growth inhibitory effect of Withania somnifera (ashwagandha) on a transplatable mouse tumor, sarcoma. Ind J Exp Biol 2009;45:67-90.
  29. Nieto J, Cleveland KL, Vieira S, Caleja C. Efficacy of antioxidant defense mechanism during inflammation. Infect Immun 2000;54:554-9.
  30. Sankar H, Manivasagam D. Effect of higher doses of ashwagandha on superoxide levels in the cultured mouse macrophages. J Nat Med 2007;67:436-78.
  31. Agarwal R, Diwanay S, Patki P, Patwardhan B. Studies on immuno-modulatory activity of Withania somnifera (ashwagandha) extracts in experimental immune inflammation. J Ethanopharmocol 1999;67:27-35.
  32. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000;5:334-46.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.